Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $152.0000 (0.46%) ($149.8200 - $153.0200) on Tue. Feb. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.04% (three month average) | RSI | 60 | Latest Price | $152.0000(0.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(22%) XLV(18%) XBI(17%) XOP(16%) SPLV(14%) | Factors Impacting ABBV price | ABBV will decline at least -0.52% in a week (0% probabilities). XLC(-13%) IPO(-10%) VXX(-8%) BWX(-7%) XLK(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.52% (StdDev 1.04%) | Hourly BBV | 2.2 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $151.3(0.46%) | 10 Day Moving Average | $150.19(1.21%) | 20 Day Moving Average | $148.36(2.45%) | To recent high | -8.7% | To recent low | 5.1% | Market Cap | $268.171b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |